• Hematologic Malignancies Program

• Diagnosis and Treatment...
• Physicians and Staff
• Q&A with Dr. Maria Baer
• Patient Education...
• 
    Related Resources
• Clinical Trials
• Information for Patients

Hematologic Malignancies Program

Patient and Family Education

Myelodysplastic Syndromes (MDS)

At The University of Maryland Marlene and Stewart Greenebaum Cancer Center, patients with MDS are treated in the Center's Program for Hematologic Malignancies, which is staffed by experts in the research and treatment of diseases of the blood.

UMGCC also has a Blood and Marrow Transplant Program, which specializes in transplants for patients with leukemia and other cancers.

The Center's medical staff members take a fully integrated, multidisciplinary approach to cancer care so that every phase of treatment is coordinated for maximum effectiveness. Patients receive the most advanced and comprehensive treatment available anywhere in the world—in a compassionate and supportive setting.

To make an appointment, call our toll-free number: 1-800-888-8823

This page was last updated on: October 7, 2009.

---

For More Information

• Have questions about hematologic malignancies? Ask our Team of Experts.
• Patient Handbook (PDF)

Please rate the quality of this article. Do you find this article to be helpful / informative?                Poor                                       Excellent Do you have any brief comments on this page: (up to 255 characters) Note: If you have a question, please contact Ask the Expert.

Email this Page                                                                     Print this Page